Insider information: Testing cancer drug sensitivity for personalized therapy

Cancer death is usually caused by incurable drug-resistant and metastatic cancers. Although tremendous progress has been made in anticancer drug development during the past two decades, cancer medicine still faces unprecedented challenges associated with choosing effective treatments for individual...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jing, Wei, Qiang, Ye, Jixing, Denduluri, Sahitya K., Wang, Xin, Mohammed, Maryam K., Luu, Hue H., Haydon, Rex C., He, Tong-Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chongqing Medical University 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610196/
https://www.ncbi.nlm.nih.gov/pubmed/26491709
http://dx.doi.org/10.1016/j.gendis.2015.05.004
Descripción
Sumario:Cancer death is usually caused by incurable drug-resistant and metastatic cancers. Although tremendous progress has been made in anticancer drug development during the past two decades, cancer medicine still faces unprecedented challenges associated with choosing effective treatments for individual patients. Three recent reports have offered encouraging approaches towards potentially personalized cancer drug selection.

Ejemplares similares